glp-1 vs glp-2 weight loss Part 1 of a 3-Part Series; Medications for What 2 Months Really Looks

The time it takes for a peptide can be measured by its half-life , which mathematically is defined as the time it takes for half of the initial amount of peptide to disappear

Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol

To me, if we are going to talk about combination therapy, we need to look at those antidiabetic medications that have documented cardiovascular benefit, DeFronzo said

N Engl J Med 346:393403 Bailey CJ, Turner RC (1996) Metformin

DOI: 10.1097/01.NPR.0000000000000430,